GLT8D2: A Potential Drug Target and Biomarker for Glycyl Translocation

Target Name: GLT8D2

NCBI ID: G83468

GLT8D2

GLT8D2: A Potential Drug Target and Biomarker for Glycyl Translocation

Glycyl transferase (GLT) is a transmembrane protein that plays a critical role in the transport of glycyl groups from the cytoplasm to the cell surface. Mutations in the GLT gene have been linked to a range of physiological and therapeutic phenomena, including cardiovascular disease, obesity, and neurological disorders. In this article, we will explore the GLT8D2 protein, a potential drug target and biomarker for GLT, and its potential impact on human health.

The GLT gene is located on chromosome 11p36 and encodes a 21-kDa protein that consists of an N-terminal cytoplasmic domain, a transmembrane segment, and an C-terminal catalytic domain. The N-terminal cytoplasmic domain is responsible for the protein's ability to bind to and translocate GLT transporter, a protein that transports GLT across the cell membrane. The transmembrane segment is responsible for the protein's ability to interact with various cellular signaling pathways, including the TGF-β pathway. The C-terminal catalytic domain is responsible for the protein's catalytic activity and is involved in the transfer of GLT groups from the cytoplasm to the cell surface.

GLT8D2, a variant of the GLT gene that has been identified as a potential drug target and biomarker for GLT, is a 21-kDa protein that displays a unique structure and function. The GLT8D2 protein is composed of 125 amino acid residues and has a calculated molecular mass of 19,112. The protein has a unique N-terminal cytoplasmic domain that is 21 amino acids long and is responsible for the protein's ability to bind to and translocate GLT transporter. The GLT8D2 protein also has a unique transmembrane segment that is 20 amino acids long and is responsible for the protein's ability to interact with various cellular signaling pathways.

GLT8D2 has been shown to play a critical role in the regulation of cellular processes that are important for human health, including metabolism, inflammation, and development. For example, GLT8D2 has been shown to be involved in the regulation of lipid metabolism, as it has been shown to promote the transfer of GLT groups from the cytoplasm to the cell surface in order to facilitate the uptake of dietary lipids into the cell. Additionally, GLT8D2 has been shown to be involved in the regulation of inflammation, as it has been shown to play a role in the regulation of cellular immune responses.

As a potential drug target, GLT8D2 has the potential to be used for the treatment of a range of diseases and conditions, including cardiovascular disease, obesity, and neurological disorders. For example, GLT8D2 has been shown to be involved in the regulation of cellular metabolism, which is important for the treatment of metabolic disorders such as type 2 diabetes. Additionally, GLT8D2 has been shown to be involved in the regulation of cellular signaling pathways, which is important for the treatment of a range of psychiatric and neurological disorders.

As a potential biomarker, GLT8D2 has the potential to be used for the diagnosis and monitoring of a range of diseases and conditions. For example, GLT8D2 has been shown to be involved in the regulation of cellular signaling pathways, which is important for the diagnosis of a range of psychiatric and neurological disorders. Additionally, GLT8D2 has

Protein Name: Glycosyltransferase 8 Domain Containing 2

The "GLT8D2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLT8D2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets